Universitätsklinikum Köln

Fraktionelle Flussreserve in der Diagnostik der koronaren Herzerkrankung: Klinische Bedeutung, Durchführung und Interpretation (2016) Möllmann H, Rudolph T, Rieber J, Eggebrecht H, Richardt G, Schmitz T, Werner N, Achenbach S Journal article NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas (2016) Meder L, Koenig K, Ozretic L, Schultheis AM, Ueckeroth F, Ade CP, Albus K, et al. Journal article Metabolic connectivity mapping reveals effective connectivity in the resting human brain (2016) Riedl V, Utz L, Castrillon G, Grimmer T, Rauschecker JP, Ploner M, Friston KJ, et al. Journal article Communication issues with patients with incurable cancer and palliative management and care in the dying phase - Keine leichte Aufgabe: Patient liegt im Sterben: Sicher erkennen, angemessen handeln und darüber reden (2016) Doll A, Montag T, Simon ST, Bausewein C, Voltz R, Ostgathe C Journal article Elucidating alternative pathways triggering small cell lung carcinoma tumor biology (2016) Meder L, Buettner R Journal article COMBINED ALTERATIONS IN MAPK PATHWAY GENES, CDKN2A/B AND ATRX CHARACTERIZE ANAPLASTIC PILOCYTIC ASTROCYTOMA (2016) Kratz A, Sahm F, Schrimpf D, Jones DT, Reuss D, Koelsche C, Huang K, et al. Conference contribution DISEASE PROGRESSION IN 282 PATIENTS WITH UNDIFFERENTIATED SSC - DATA FROM THE GERMAN NETWORK FOR SYSTEMIC SCLERODERMA (2016) Moinzadeh P, Blank N, Siegert E, Henes J, Susok L, Distler J, Juche A, et al. Conference contribution Cetuximab in combination with platinum-based chemotherapy or radiotherapy in recurent and/or metastatic SCCHN in a non-selected patient cohort (interim analysis of the phase IV SOCCER trial) (2016) Hecht M, Hahn D, Beutner D, Reichert D, Goehler T, Wurm R, Welslau M, et al. Conference contribution Outcome on 560 metastatic melanoma (MM) patients treated with pembrolizumab during the German Expanded Access Program (EAP) (2016) Hassel J, Forschner A, Bluhm L, Heinzerling L, Zimmer L, Utikal J, Kaehler K, et al. Conference contribution Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab (2016) Weide B, Martens A, Hassel JC, Berking C, Postow MA, Bisschop K, Simeone E, et al. Journal article